Accepted answer
0.8 percentage points, and the direction is the informative half. Medutest reports 97.1 per cent and the certificate 97.9, so the independent figure is lower. As impurity that is 2.9 per cent against 2.1 — 1.38 times as much unassigned area. A gentler gradient resolves impurities that a steeper one hides beneath the main peak, so the better method routinely reports the worse number; 0.8 points is comfortably inside what method choice alone produces on identical material. Ask both parties for the method section before you decide which figure is wrong, because the answer is often neither.
The method matters more than the vial, which is why specifying a method buys you far more than changing suppliers does.
Temperature affects the dynamics of molecular conformation, and if a peptide has proline residues that interconvert on the chromatographic timescale, the peak will split or shoulder at low temperature and collapse at high temperature.
Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.
The ICH Q3A impurity thresholds and the relevant pharmacopoeial chapters all specify method validation requirements that almost no research-grade certificate claims to meet.
If you are ranking vendors, specify a method and have all samples tested at the same place.
7The system-suitability data is the part that tells you whether to believe the rest. – pascal_thibault 8 months ago 8Confirming from the other direction: I ignored the method section once and paid for it. – bac_or_bust 10 months ago add a comment